Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Kidney Int. 2010 Dec 8;79(5):563–572. doi: 10.1038/ki.2010.467

Table 3. Diabetic Nephropathy Candidate Loci.

GWAS, Replication, and Combined (GWAS+Replication) P values for diabetic nephropathy candidate loci across the genome.

MAF: Minor Allele Frequency. OR: Odds Ratio. 95% CI: 95% Confidence Interval.

Locus
GWAS
T2DM-ESRD (n=965)
Controls (n=1029)
Replication
T2DM-ESRD (n=709)
Controls (n=690)
Combined
T2DM-ESRD (n=1674)
Controls (n=1719)
Marker Chr Position Nearest
Gene(s)
Minor
Allele
(Major
Allele)
MAF
T2DM-
ESRD
MAF
Control
Additive
P value
MAF
T2DM-
ESRD
MAF
Control
Additive
P value
Additive
P value
OR
(95% CI)




rs10888287 1 246,184,039 OR2L13 G(T) 0.439 0.503 5.03E-04 0.444 0.495 0.0482 5.97E-05 0.82 (0.75–0.90)
rs4260465 3 164,231,046 No gene G(C) 0.364 0.414 4.31E-04 0.381 0.421 0.0382 4.50E-05 0.81 (0.74–0.90)
rs11730446 4 96,382,267 UNC5C G(A) 0.459 0.403 6.23E-04 0.459 0.424 0.0465 1.24E-04 1.21 (1.10–1.33)
rs891382 4 147,371,790 SLC10A7/LSM6 G(A) 0.085 0.059 3.19E-04 0.081 0.065 0.0183 2.42E-05 1.49 (1.24–1.80)
rs7697691 4 182,853,951 No gene G(A) 0.243 0.285 0.0016 0.243 0.285 0.0127 7.37E-05 0.80 (0.72–0.89)
rs3822908 6 97,706,333 C6orf167 C(T) 0.125 0.162 3.63E-04 0.121 0.147 0.0462 4.52E-05 0.75 (0.65–0.86)
rs7760831 6 102,071,536 GRIK2 C(T) 0.176 0.222 2.55E-04 0.193 0.224 0.0455 3.48E-05 0.77 (0.69–0.87)
rs208865 6 130,114,249 C6orf191/ARHGAP18 T(C) 0.118 0.082 2.14E-04 0.115 0.091 0.0364 2.90E-05 1.41 (1.20–1.66)
rs9493454 6 133,186,322 RPS12 C(A) 0.439 0.376 4.91E-04 0.453 0.395 0.0089 1.72E-05 1.24 (1.13–1.37)
rs7769051 6 133,188,489 RPS12 A(C) 0.349 0.289 4.06E-04 0.362 0.3 0.0012 2.20E-06 1.28 (1.16–1.42)
rs6930576 6 148,746,647 SASH1 A(G) 0.337 0.276 1.87E-05 0.319 0.274 0.0099 7.04E-07 1.31 (1.18–1.45)
rs773506 9 93,015,292 AUH A(G) 0.179 0.233 3.27E-04 0.174 0.223 0.0130 6.45E-06 0.76 (0.67–0.85)
rs11175885 12 64,400,897 C12orf66/TMEM5 G(A) 0.181 0.234 0.0013 0.19 0.249 0.0106 2.18E-05 0.77 (0.68–0.87)
rs2358944 12 64,403,825 MSRB3/HMGA2 A(G) 0.178 0.232 9.48E-04 0.188 0.256 0.0018 3.54E-06 0.75 (0.67–0.85)
rs2904532 12 65,582,311 GRIP1/CAND1 G(A) 0.141 0.183 8.17E-04 0.148 0.184 0.0172 4.87E-05 0.76 (0.67–0.87)
rs11176482 12 65,582,814 GRIP1/CAND1 C(T) 0.141 0.184 7.08E-04 0.147 0.182 0.0202 4.79E-05 0.76 (0.67–0.87)
rs12302041 12 76,654,356 NAV3 A(G) 0.085 0.055 3.09E-04 0.088 0.06 0.0149 1.15E-05 1.54 (1.27–1.87)
rs1978243 14 86,596,160 No gene T(C) 0.22 0.274 7.53E-04 0.221 0.274 0.0105 1.61E-05 0.78 (0.70–0.87)
rs6494387 15 61,132,579 TPM1 A(G) 0.367 0.311 2.32E-04 0.358 0.32 0.0209 1.80E-05 1.25 (1.13–1.39)
rs1034589 22 29,909,233 RNF185 C(T) 0.036 0.062 0.0010 0.033 0.065 0.0055 1.06E-05 0.59 (0.46–0.74)
rs2106294 22 29,975,759 LIMK2 C(T) 0.035 0.062 7.49E-04 0.031 0.064 0.0028 4.11E-06 0.57 (0.45–0.72)
rs4820043 22 29,977,094 LIMK2 A(G) 0.036 0.062 0.0010 0.031 0.065 0.0026 5.07E-06 0.57 (0.45–0.73)
rs5749286 22 30,230,359 SFI1 A(C) 0.038 0.065 0.0013 0.036 0.068 0.0030 9.79E-06 0.60 (0.47–0.75)
rs16996381 22 34,841,225 APOL3 G(A) 0.336 0.391 0.0018 0.371 0.432 0.0191 1.06E-04 0.82 (0.75–0.91)
rs735853 22 35,009,161 MYH9 G(C) 0.082 0.123 4.59E-04 0.079 0.118 0.0091 1.20E-05 0.69 (0.59–0.82)